首页 | 本学科首页   官方微博 | 高级检索  
     

对比剂急性肾损伤的风险评估及预防
引用本文:张慧,徐放,任金锐,李方达,宋希涛,郑月宏. 对比剂急性肾损伤的风险评估及预防[J]. 中华老年多器官疾病杂志, 2021, 20(12): 928-931
作者姓名:张慧  徐放  任金锐  李方达  宋希涛  郑月宏
作者单位:中国医学科学院北京协和医院血管外科,北京 100730,中国医学科学院北京协和医院血管外科,北京 100730;河北北方学院研究生院,河北 张家口 075000,中国医学科学院北京协和医院血管外科,北京 100730,中国医学科学院北京协和医院血管外科,北京 100730,中国医学科学院北京协和医院血管外科,北京 100730,中国医学科学院北京协和医院血管外科,北京 100730
基金项目:国家自然科学基金 (51890894,81770481,82070492)
摘    要:介入技术的问世在为临床诊疗开辟新途径的同时,也伴随着对程序安全性的不断改善。不论是外周血管还是心脑血管介入,大多都需要在血管内施用对比剂,而对比剂的使用有引起急性肾损伤的风险,会产生主要并发症、延长住院时间、造成不良预后。本文聚焦对比剂造成的急性肾损伤这一临床问题,对其病理生理学、诊断、预测因素和临床处理进行综述,总结此类问题的风险处理策略。

关 键 词:危险因素  对比剂急性肾损伤  病理生理  临床管理
收稿时间:2021-05-25

Risk assessment and prevention of contrast-induced acute kidney injury:a review
ZHANG Hui,XU Fang,REN Jin-Rui,LI Fang-D,SONG Xi-Tao and ZHENG Yue-Hong. Risk assessment and prevention of contrast-induced acute kidney injury:a review[J]. Chinese Journal of Multiple Organ Diseases in the Elderly, 2021, 20(12): 928-931
Authors:ZHANG Hui  XU Fang  REN Jin-Rui  LI Fang-D  SONG Xi-Tao  ZHENG Yue-Hong
Affiliation:Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China,Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China;Graduate School of Hebei North University, Zhangjiakou 075000, Hebei Province, China,Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China,Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China,Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China and Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
Abstract:The advent of interventional technology has generated new approaches to clinical diagnosis and treatment, and its develop-ment has also been accompanied by continuous improvements in procedure safety. Regardless of whether in peripheral vascular intervention or in cardiovascular and cerebrovascular intervention, intravascular administration of contrast agents is mostly required, and the use of contrast agents has the risk of causing acute kidney injury, leading to major complications, prolonged hospital stay, and poor prognosis. This article reviews the clinical problem of acute contrast-induced kidney injury in the respects of its pathophysiology, diagnosis, predictive factors, and clinical management, with a view to providing references in clinical decisions.
Keywords:risk factors   contrast-induced acute kidney injury   pathophysiology   clinical management This work was supported by the National Natural Science Foundation of China
点击此处可从《中华老年多器官疾病杂志》浏览原始摘要信息
点击此处可从《中华老年多器官疾病杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号